(Q40286733)

PubMed publication ID

16985958

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16985958%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Benign prostatic hyperplasia: does prostate size matter? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1502356&resulttype=core&format=json

10 May 2020

main subject

prostatic hypertrophy

1 reference

J Curtis Nickel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1502356&resulttype=core&format=json

10 May 2020

publication date

1 January 2003

1 reference

PubMed publication ID

16985958

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16985958%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1502356&resulttype=core&format=json

10 May 2020

volume

5 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1502356&resulttype=core&format=json

10 May 2020

page(s)

S12-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1502356&resulttype=core&format=json

Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.

10 May 2020

cites work

1 reference

12 December 2020

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo

1 reference

12 December 2020

Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group

1 reference

12 December 2020

Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.

1 reference

12 December 2020

Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials

1 reference

12 December 2020

Natural history of prostatism: risk factors for acute urinary retention

1 reference

12 December 2020

Reducing the risk of benign prostatic hyperplasia progression

1 reference

12 December 2020

Symptoms and signs of prostatism as risk factors for prostatectomy

1 reference

12 December 2020

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

12 December 2020

Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound

1 reference

12 December 2020

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

12 December 2020

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia

1 reference

12 December 2020

Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status

1 reference

12 December 2020

Longitudinal changes in peak urinary flow rates in a community based cohort

1 reference

12 December 2020

Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.

1 reference

12 December 2020

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study

1 reference

12 December 2020

Benign prostatic hyperplasia: a progressive disease of aging men.

1 reference

12 December 2020

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

12 December 2020

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

12 December 2020

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1502356&resulttype=core&format=json

10 May 2020

PubMed publication ID

16985958

1 reference